Successful treatment with humanized anti–interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever-Reference-Cited by-同舟云学术

Successful treatment with humanized anti–interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever

Published:2015-01-25 Issue:4 Volume:26 Page:610-613
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Hamanoue Satoshi¹,Suwabe Tatsuya¹,Hoshino Junichi¹,Sumida Keiichi¹,Mise Koki¹,Hayami Noriko¹,Sawa Naoki¹,Takaichi Kenmei¹²,Fujii Takeshi³,Ohashi Kenichi³,Yazaki Masahide⁴,Ikeda Shuichi⁴,Ubara Yoshifumi¹²

Affiliation:

1. Nephrology Center, Toranomon Hospital, Tokyo, Japan

2. Okinaka Memorial Institute for Medical Research, Tokyo, Japan

3. Department of Pathology, Toranomon Hospital, Tokyo, Japan

4. Departments of Medicine (Neurology and Rheumatology) and Pediatrics, Shinshu University School of Medicine, Matsumoto; and the National Center of Neurology and Psychiatry, Tokyo, Japan

Publisher

Informa UK Limited

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.3109/14397595.2014.908810

Reference16 articles.

1. Familial Mediterranean fever

2. Colchicine in the Prevention and Treatment of the Amyloidosis of Familial Mediterranean Fever

3. The relation between familial Mediterranean fever and amyloidosis

4. Familial Mediterranean fever in Arabs

5. Clinical and Genetic Features of Familial Mediterranean Fever in Japan

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Could tocilizumab be used in familial Mediterranean fever? A systematic review;Rheumatology;2024-07-01

2. Gastric, Colonic, and Rectal Amyloidosis in the Setting of Familial Mediterranean Fever: A Unique Cause of Intractable Diarrhea;Case Reports in Gastrointestinal Medicine;2024-01-23

3. Vector autoregression: Useful in rare diseases?—Predicting organ response patterns in a rare case of secondary AA amyloidosis;PLOS ONE;2023-08-10

4. Serum amyloid A and metabolic disease: evidence for a critical role in chronic inflammatory conditions;Frontiers in Cardiovascular Medicine;2023-06-15

5. Interleukin-6 inhibition in the treatment of autoinflammatory diseases;Frontiers in Immunology;2022-07-26